LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 84.06 | 21.74 | 9677 | 6152 | 1.5729 | 1.1144 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 84.06 | 21.74 | 8225 | 6152 | 1.3369 | 1.0726 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 84.06 | 21.74 | 10350 | 6152 | 1.6823 | 1.1319 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 86.03 | 21.74 | 9740 | 6155 | 1.5824 | 1.1159 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 86.03 | 21.74 | 9882 | 6155 | 1.6054 | 1.1197 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 86.03 | 21.74 | 6604 | 6155 | 1.0729 | 1.0173 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 86.03 | 21.74 | 10558 | 6155 | 1.7153 | 1.1370 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 88.00 | 21.74 | 9998 | 6081 | 1.6440 | 1.1261 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 88.00 | 21.74 | 10171 | 6081 | 1.6725 | 1.1306 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 88.00 | 21.74 | 5427 | 6081 | 0.8924 | 0.9722 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 88.00 | 21.74 | 10813 | 6081 | 1.7780 | 1.1467 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 89.97 | 21.74 | 9907 | 6084 | 1.6283 | 1.1236 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 89.97 | 21.74 | 10398 | 6084 | 1.7090 | 1.1363 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 89.97 | 21.74 | 4742 | 6084 | 0.7794 | 0.9396 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 89.97 | 21.74 | 11143 | 6084 | 1.8314 | 1.1546 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 91.94 | 21.74 | 10104 | 6121 | 1.6505 | 1.1270 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 91.94 | 21.74 | 10661 | 6121 | 1.7415 | 1.1411 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 91.94 | 21.74 | 3705 | 6121 | 0.6052 | 0.8803 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 91.94 | 21.74 | 11411 | 6121 | 1.8640 | 1.1591 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 93.92 | 21.74 | 9441 | 6070 | 1.5554 | 1.1117 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 93.92 | 21.74 | 10834 | 6070 | 1.7848 | 1.1478 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 93.92 | 21.74 | 2825 | 6070 | 0.4654 | 0.8203 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 93.92 | 21.74 | 11695 | 6070 | 1.9267 | 1.1681 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 2.24 | 21.74 | 436 | 183 | 2.3751 | 1.6490 | MN20160310_N01 | H11 |